CEA logo.png
CEA Industries Inc. Reports First Quarter 2024 Results and Provides Update on Strategic Review Process
14 mai 2024 16h50 HE | CEA Industries Inc.
Louisville, Colorado, May 14, 2024 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) (“CEA Industries” or the “Company”), is reporting results for the three months ended March 31, 2024. ...
Logo.png
BioRestorative Therapies Provides First Quarter 2024 Business Update
14 mai 2024 16h10 HE | BioRestorative Therapies, Inc
MELVILLE, N.Y., May 14, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based...
Logo.png
IMUNON Reports First Quarter 2024 Financial Results and Provides Business Update
13 mai 2024 08h00 HE | Imunon, Inc.
Conference Call Begins Today at 11:00 a.m. Eastern Time LAWRENCEVILLE, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on...
Logo.png
GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
13 mai 2024 08h00 HE | GRI Bio, Inc.
Interim data readout of Phase 2a biomarker study evaluating lead program GRI-0621 for the treatment of Idiopathic Pulmonary Fibrosis (IPF) expected Q3 2024 and topline data on track for Q4 2024 ...
Logo 1jpg.jpg
Research Frontiers Reports First Quarter 2024 Financial Results and Will Host a Conference Call at 5:30p.m. Today
09 mai 2024 16h01 HE | Research Frontiers Incorporated
WOODBURY, N.Y., May 09, 2024 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced its financial results for its first quarter of 2024. Management will host a conference call today at...
InterpaceBiosciences_New Logo.png
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
09 mai 2024 16h01 HE | Interpace Biosciences, Inc.
 ●Q1 Revenue of $10.3 million; a 4% increase year-over-year ●Q1 Test volume up 10% year over year to record levels PARSIPPANY, NJ, May 09, 2024 (GLOBE NEWSWIRE) -- Interpace Biosciences, Inc....
LOGO.png
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
09 mai 2024 08h00 HE | NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider...
SURO CAPITAL_highres CROPPED.jpg
SuRo Capital Corp. Reports First Quarter 2024 Financial Results
08 mai 2024 16h05 HE | SuRo Capital Corp.
Net Asset Value of $7.17 Per Share as of March 31, 2024 Completed $35 Million in New Investments Year-to-Date NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the...
Gilat Logo Full Color.png
Gilat Reports First Quarter 2024 Results
08 mai 2024 07h05 HE | Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today...
Logo.jpg
RYVYL to Announce First Quarter 2023 Financial Results on Tuesday, May 14, 2024
06 mai 2024 08h00 HE | RYVYL Inc.
SAN DIEGO, CA , May 06, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL” or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger...